Group by:
Date |
Item TypeReview
Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010.
Brennecke, B. and Gazzi, T. and Atz, K. and Fingerle, J. and Kuner, P. and Schindler, T. and de Weck, G. and Nazaré, M. and Grether, U.
Pharmaceutical Patent Analyst 10
(3): 111-163.
May 2021
The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptors.
Haberland, A. and Wallukat, G. and Schimke, I.
Pharmaceutical Patent Analyst 2
(2): 231-248.
March 2013
This list was generated on Mon Apr 29 02:32:54 2024 CEST.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
